CAD 6.44
(0.63%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 2.72 Billion USD | -19.71% |
2022 | 3.39 Billion USD | -0.35% |
2021 | 3.41 Billion USD | 317.94% |
2020 | 816.11 Million USD | 38.12% |
2019 | 590.89 Million USD | 264.59% |
2018 | 162.07 Million CAD | 181252.13% |
2017 | 89.36 Thousand CAD | -13.82% |
2016 | 103.7 Thousand CAD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 2.81 Billion USD | 3.31% |
2024 Q2 | 2.86 Billion USD | 1.62% |
2023 FY | 2.72 Billion USD | -19.71% |
2023 Q2 | 2.8 Billion USD | -15.31% |
2023 Q4 | 2.72 Billion USD | -1.66% |
2023 Q1 | 3.31 Billion USD | -2.43% |
2023 Q3 | 2.77 Billion USD | -1.19% |
2022 Q4 | 3.39 Billion USD | 2.35% |
2022 FY | 3.39 Billion USD | -0.35% |
2022 Q1 | 3.52 Billion USD | 3.37% |
2022 Q2 | 3.46 Billion USD | -1.75% |
2022 Q3 | 3.32 Billion USD | -4.14% |
2021 Q1 | 897.45 Million USD | 9.97% |
2021 FY | 3.41 Billion USD | 317.94% |
2021 Q4 | 3.41 Billion USD | 167.3% |
2021 Q3 | 1.27 Billion USD | 11.32% |
2021 Q2 | 1.14 Billion USD | 27.73% |
2020 FY | 816.11 Million USD | 38.12% |
2020 Q4 | 816.11 Million USD | 3.81% |
2020 Q3 | 786.17 Million USD | 12.68% |
2020 Q2 | 697.69 Million USD | 8.99% |
2020 Q1 | 640.14 Million USD | 8.34% |
2019 Q2 | 372.62 Million USD | 68.88% |
2019 Q4 | 590.89 Million USD | 33.64% |
2019 Q3 | 442.15 Million USD | 18.66% |
2019 Q1 | 220.64 Million CAD | 36.14% |
2019 FY | 590.89 Million USD | 264.59% |
2018 Q2 | 43.61 Thousand CAD | -33.41% |
2018 Q4 | 162.07 Million CAD | 15.69% |
2018 FY | 162.07 Million CAD | 181252.13% |
2018 Q1 | 65.5 Thousand CAD | -26.71% |
2018 Q3 | 140.09 Million CAD | 321089.99% |
2017 Q4 | 89.36 Thousand CAD | -16.16% |
2017 Q1 | - USD | -100.0% |
2017 Q3 | 106.58 Thousand CAD | 0.0% |
2017 FY | 89.36 Thousand CAD | -13.82% |
2016 Q4 | 103.7 Thousand CAD | 0.0% |
2016 FY | 103.7 Thousand CAD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Aion Therapeutic Inc. | 210.67 Thousand CAD | -1295304.705% |
Ayurcann Holdings Corp. | 14.85 Million CAD | -18272.674% |
Blueberries Medical Corp. | 2.41 Million CAD | -112826.538% |
The BC Bud Corporation | 632.06 Thousand CAD | -431667.41% |
BioNxt Solutions Inc. | 1.26 Million CAD | -215200.377% |
CordovaCann Corp. | 10.26 Million CAD | -26489.372% |
Christina Lake Cannabis Corp. | 15.96 Million CAD | -16996.646% |
Captor Capital Corp. | 33.85 Million CAD | -7961.135% |
City View Green Holdings Inc. | 3846.00 CAD | -70958168.331% |
1CM Inc. | 34.01 Million CAD | -7922.205% |
Global Hemp Group Inc. | 42.76 Thousand CAD | -6382012.205% |
Greenway Greenhouse Cannabis Corporation | 33.08 Million CAD | -8147.589% |
IM Cannabis Corp. | 48.81 Million CAD | -5490.836% |
Lobe Sciences Ltd. | 2.29 Million CAD | -118580.83% |
Maple Leaf Green World Inc. | 168.27 Thousand CAD | -1621702.072% |
Mountain Valley MD Holdings Inc. | 8.96 Million CAD | -30337.821% |
Nextleaf Solutions Ltd. | 8.53 Million CAD | -31867.246% |
Ovation Science Inc. | 76.88 Thousand CAD | -3549290.022% |
Pharmadrug Inc. | 1.45 Million CAD | -186861.785% |
Captiva Verde Wellness Corp. | 9.1 Million CAD | -29882.044% |
RAMM Pharma Corp. | 32.3 Million CAD | -8348.983% |
RIV Capital Inc. | 1.74 Million CAD | -156692.5% |
Revive Therapeutics Ltd. | 10.63 Million CAD | -25558.881% |
Red White & Bloom Brands Inc. | 234.25 Million CAD | -1065.003% |
SLANG Worldwide Inc. | 33.2 Million CAD | -8119.288% |
1933 Industries Inc. | 18.01 Million CAD | -15044.817% |
Red Light Holland Corp. | 24.08 Million CAD | -11231.421% |
Top Strike Resources Corp. | 11.73 Million CAD | -23155.28% |
Xebra Brands Ltd. | 379.36 Thousand CAD | -719268.792% |
Adastra Holdings Ltd. | 32.34 Million CAD | -8337.913% |